Literature DB >> 25840805

Local Injection of Lenti-BDNF at the Lesion Site Promotes M2 Macrophage Polarization and Inhibits Inflammatory Response After Spinal Cord Injury in Mice.

Xin-Chao Ji1, Yuan-Yuan Dang, Hong-Yan Gao, Zhao-Tao Wang, Mou Gao, Yi Yang, Hong-Tian Zhang, Ru-Xiang Xu.   

Abstract

There is much evidence to suggest that brain-derived neurotrophic factor (BDNF) is a prominent candidate in promoting neuroprotection, axonal regeneration, and synaptic plasticity following spinal cord injury (SCI). Although some evidence indicates that BDNF has potent anti-oxidative effects and may be involved in the regulation of the immune response, the effects of BDNF in the inflammatory response during the course of secondary damage after SCI is still unclear. The present study was designed to investigate the effects of BDNF with a special focus on their effect on macrophage polarization after SCI. Adult C57 mice underwent T10 spinal cord clip compression injury and received lenti-BDNF vector injections at the epicenter of the lesion site. Four days later, total BDNF levels were greatly increased in animals that received lenti-BDNF injections. Confocal imaging showed that more than 80 % of the lenti-virus infected cells were CD11b-positive macrophages. In addition, the expression of arginase-1 and CD206 (associated with M2 macrophage phenotype) significantly increased in the animals that received lenti-BDNF injections compared with those that received lenti-EGFP injections. On the contrary, the expression of CD16/32 and inducible nitric oxide synthase (M1 phenotype marker) was down-regulated as demonstrated using flow cytometry and immunohistochemistry. Furthermore, the production of interleukin 1β and tumor necrosis factor alpha was significantly reduced whereas the levels of interleukin 10 and interleukin 13 were elevated in subjects that received lenti-BDNF vector injections. The time course of functional recovery revealed that gradual recovery was observed in the subacute phase in lenti-BDNF group, little improvement was observed in lenti-EGFP group. At the axonal level, significant retraction of the CST axons were observed in lenti-EGFP injected animals relative to lenti-BDNF group by biotinylated dextran amine tracing. In addition, compared to lenti-BDNF group markedly demyelination was observed in the lenti-EGFP group using luxol fast blue staining. In conclusion, we found that BDNF could promote the shift of M1 to M2 phenotype and ameliorate the inflammatory microenvironment. Furthermore, the roles of BDNF in immunity modulation may enhance neuroprotective effects and partially contribute to the locomotor functional recovery after SCI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25840805     DOI: 10.1007/s10571-015-0182-x

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  42 in total

1.  Local acute application of BDNF in the lesioned spinal cord anti-inflammatory and anti-oxidant effects.

Authors:  E A J Joosten; D A Houweling
Journal:  Neuroreport       Date:  2004-05-19       Impact factor: 1.837

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 3.  Alternatively activated macrophages in spinal cord injury and remission: another mechanism for repair?

Authors:  Taekyun Shin; Meejung Ahn; Changjong Moon; Seungjoon Kim; Ki-Bum Sim
Journal:  Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.590

4.  Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains.

Authors:  D Michele Basso; Lesley C Fisher; Aileen J Anderson; Lyn B Jakeman; Dana M McTigue; Phillip G Popovich
Journal:  J Neurotrauma       Date:  2006-05       Impact factor: 5.269

5.  Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.

Authors:  Ralf A Linker; De-Hyung Lee; Seray Demir; Stefan Wiese; Niels Kruse; Ines Siglienti; Ellen Gerhardt; Harald Neumann; Michael Sendtner; Fred Lühder; Ralf Gold
Journal:  Brain       Date:  2010-08       Impact factor: 13.501

6.  PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration.

Authors:  Yingjie Shen; Alan P Tenney; Sarah A Busch; Kevin P Horn; Fernando X Cuascut; Kai Liu; Zhigang He; Jerry Silver; John G Flanagan
Journal:  Science       Date:  2009-10-15       Impact factor: 47.728

7.  SOCS3 deficiency promotes M1 macrophage polarization and inflammation.

Authors:  Hongwei Qin; Andrew T Holdbrooks; Yudong Liu; Stephanie L Reynolds; Lora L Yanagisawa; Etty N Benveniste
Journal:  J Immunol       Date:  2012-08-27       Impact factor: 5.422

8.  Neurotrophins and their receptors in human lingual tonsil: an immunohistochemical analysis.

Authors:  Marco Artico; Elena Bronzetti; Laura M Felici; Valentina Alicino; Brunella Ionta; Benedetto Bronzetti; Giuseppe Magliulo; Claudia Grande; Loris Zamai; Guido Pasquantonio; Marco De Vincentiis
Journal:  Oncol Rep       Date:  2008-11       Impact factor: 3.906

9.  Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats.

Authors:  Vanessa S Boyce; Jihye Park; Fred H Gage; Lorne M Mendell
Journal:  Eur J Neurosci       Date:  2011-12-30       Impact factor: 3.386

10.  Long-term viral brain-derived neurotrophic factor delivery promotes spasticity in rats with a cervical spinal cord hemisection.

Authors:  Karim Fouad; David J Bennett; Romana Vavrek; Armin Blesch
Journal:  Front Neurol       Date:  2013-11-19       Impact factor: 4.003

View more
  21 in total

1.  The Severity of Spinal Cord Injury Determines the Inflammatory Gene Expression Pattern after Immunization with Neural-Derived Peptides.

Authors:  Elisa García; Raúl Silva-García; Adrian Flores-Romero; Liliana Blancas-Espinoza; Roxana Rodríguez-Barrera; Antonio Ibarra
Journal:  J Mol Neurosci       Date:  2018-05-23       Impact factor: 3.444

2.  Brain-Derived Neurotrophic Factor Inhibits Peptidoglycan-Induced Inflammatory Cytokine Expression in Human Dental Pulp Cells.

Authors:  Katsuhiro Takeda; Naoko Tokunaga; Yusuke Aida; Mikihito Kajiya; Kazuhisa Ouhara; Shinya Sasaki; Noriyoshi Mizuno; Tsuyoshi Fujita; Hidemi Kurihara
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 3.  Tissue Engineering Approaches to Modulate the Inflammatory Milieu following Spinal Cord Injury.

Authors:  Courtney M Dumont; Daniel J Margul; Lonnie D Shea
Journal:  Cells Tissues Organs       Date:  2016-10-05       Impact factor: 2.481

Review 4.  Controlled release strategies for modulating immune responses to promote tissue regeneration.

Authors:  Courtney M Dumont; Jonghyuck Park; Lonnie D Shea
Journal:  J Control Release       Date:  2015-08-08       Impact factor: 9.776

5.  Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration.

Authors:  Ping Kei Yip; Alejandro Carrillo-Jimenez; Paul King; Anna Vilalta; Koji Nomura; Chi Cheng Chau; Alexander Michael Scott Egerton; Zhuo-Hao Liu; Ashray Jayaram Shetty; Jordi L Tremoleda; Meirion Davies; Tomas Deierborg; John V Priestley; Guy Charles Brown; Adina Teodora Michael-Titus; Jose Luis Venero; Miguel Angel Burguillos
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

6.  Transplantation of Neural Precursor Cells Attenuates Chronic Immune Environment in Cervical Spinal Cord Injury.

Authors:  Lennart Riemann; Alexander Younsi; Moritz Scherer; Guoli Zheng; Thomas Skutella; Andreas W Unterberg; Klaus Zweckberger
Journal:  Front Neurol       Date:  2018-06-08       Impact factor: 4.003

7.  Impact of BDNF Val66Met Polymorphism on Myocardial Infarction: Exploring the Macrophage Phenotype.

Authors:  Leonardo Sandrini; Laura Castiglioni; Patrizia Amadio; José Pablo Werba; Sonia Eligini; Susanna Fiorelli; Marta Zarà; Silvia Castiglioni; Stefano Bellosta; Francis S Lee; Luigi Sironi; Elena Tremoli; Silvia Stella Barbieri
Journal:  Cells       Date:  2020-04-27       Impact factor: 6.600

8.  Electroacupuncture promotes the recovery of rats with spinal cord injury by suppressing the Notch signaling pathway via the H19/EZH2 axis.

Authors:  Xin Geng; Yanghong Zou; Shipeng Li; Renli Qi; Cong Jing; Xiangqian Ding; Jinghui Li; Hualin Yu
Journal:  Ann Transl Med       Date:  2021-05

Review 9.  Macrophage polarization: a key event in the secondary phase of acute spinal cord injury.

Authors:  Xiangyi Kong; Jun Gao
Journal:  J Cell Mol Med       Date:  2016-12-13       Impact factor: 5.310

10.  Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury.

Authors:  Tao Wang; Xiao Fang; Zong-Sheng Yin
Journal:  Neural Regen Res       Date:  2018-05       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.